Nykode Therapeutics ASA Logo

Nykode Therapeutics ASA

NYKD | OL

Overview

Corporate Details

ISIN(s):
NO0010714785
LEI:
254900UKQHWYZJD22017
Country:
Norway
Address:
Gaustadalleen 21, 0349 Oslo
Sector:
Health Care
Industry:
Biotechnology

Description

Nykode Therapeutics is a leading clinical-stage biopharmaceutical company. With our intelligent modular platform and tailored hyper-targeting, we’re unlocking unlimited possibilities for the future of medicine. With our unique and innovative modular vaccine technology, we’re specifically targeting antigens to Antigen Presenting Cells, which are essential for inducing rapid, strong and long-lasting immune responses.

Social Media

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-28 07:00
Earnings Release
Nykode Therapeutics - Quarterly report Q1 2025 - Attachment: 250528 Nykode Quar…
English 4.3 MB
2025-05-28 07:00
Quarterly Report
Nykode Therapeutics - Quarterly report Q1 2025
English 3.0 KB
2025-05-27 07:00
Notice of Dividend Amount
Nykode Therapeutics ASA - Ex-dividend NOK 1.00 today
English 490 bytes
2025-05-26 16:51
Report Publication Announcement
Nykode Therapeutics – invitation to Q1 2025 financial results presentation - A…
English 125.5 KB
2025-05-26 16:51
Report Publication Announcement
Nykode Therapeutics – invitation to Q1 2025 financial results presentation
English 3.2 KB
2025-05-26 11:25
Declaration of Voting Results & Voting Rights Announcements
Nykode Therapeutics ASA - Minutes of Annual General Meeting - Attachment: 25052…
English 297.9 KB
2025-05-26 11:25
Declaration of Voting Results & Voting Rights Announcements
Nykode Therapeutics ASA - Minutes of Annual General Meeting
English 2.8 KB
2025-05-23 05:00
Regulatory News Service
Nykode Therapeutics Highlights New Data in Two Poster Presentations at the 2025…
English 176.1 KB
2025-05-23 05:00
Company Presentation
Nykode Therapeutics Highlights New Data in Two Poster Presentations at the 2025…
English 6.4 KB
2025-05-05 06:30
General Meeting Notice
Nykode Therapeutics ASA - Notice of Annual General Meeting
Norwegian 319.2 KB
2025-05-05 06:30
General Meeting Notice
Nykode Therapeutics ASA - Notice of Annual General Meeting
English 1.0 KB
2025-04-29 05:00
Annual Report
Nykode Therapeutics - Annual Report 2024
English 17.1 MB
2025-04-29 05:00
Annual Report
Nykode Therapeutics - Annual Report 2024
English 10.6 MB
2025-04-29 05:00
Report Publication Announcement
Nykode Therapeutics - Annual Report 2024
English 3.1 KB
2025-04-28 17:17
Notice of Dividend Amount
Nykode Therapeutics – Key information relating to proposed cash dividend
English 2.9 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
CHOSA Oncology AB Logo CHOSA Oncology AB Sweden CHOSA
Cinclus Pharma Holding AB Logo Cinclus Pharma Holding AB Sweden CINPHA
Circio Holding ASA Logo Circio Holding ASA Norway CRNA
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo CIZZLE BIOTECHNOLOGY HOLDINGS PLC United Kingdom CIZ
CLAL Biotechnology Industries Ltd. Logo CLAL Biotechnology Industries Ltd. Israel CBI
Combigene AB Logo Combigene AB Sweden COMBI
Compugen Ltd. Logo Compugen Ltd. Israel CGEN
Corline Biomedical AB Logo Corline Biomedical AB Sweden CLBIO
Curasight A/S Logo Curasight A/S Denmark CURAS
Curevac Logo Curevac Germany CVAC